- Home
- NEO vs VEON Comparison
NEO vs VEON Comparison
Compare NEO & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- VEON
- Stock Information
- Founded
- NEO 2001
- VEON 1992
- Country
- NEO United States
- VEON Netherlands
- Employees
- NEO N/A
- VEON N/A
- Industry
- NEO Precision Instruments
- VEON Telecommunications Equipment
- Sector
- NEO Health Care
- VEON Telecommunications
- Exchange
- NEO Nasdaq
- VEON Nasdaq
- Market Cap
- NEO 2.3B
- VEON 2.4B
- IPO Year
- NEO 1999
- VEON 1996
- Fundamental
- Price
- NEO $16.53
- VEON $39.04
- Analyst Decision
- NEO Strong Buy
- VEON Strong Buy
- Analyst Count
- NEO 10
- VEON 1
- Target Price
- NEO $20.30
- VEON $48.00
- AVG Volume (30 Days)
- NEO 756.1K
- VEON 75.3K
- Earning Date
- NEO 02-18-2025
- VEON 11-14-2024
- Dividend Yield
- NEO N/A
- VEON N/A
- EPS Growth
- NEO N/A
- VEON N/A
- EPS
- NEO N/A
- VEON N/A
- Revenue
- NEO $644,118,000.00
- VEON $3,955,000,000.00
- Revenue This Year
- NEO $12.98
- VEON $12.10
- Revenue Next Year
- NEO $9.83
- VEON $7.27
- P/E Ratio
- NEO N/A
- VEON $4.63
- Revenue Growth
- NEO 12.06
- VEON 7.36
- 52 Week Low
- NEO $12.77
- VEON $18.50
- 52 Week High
- NEO $21.22
- VEON $39.87
- Technical
- Relative Strength Index (RSI)
- NEO 44.50
- VEON 74.32
- Support Level
- NEO $17.24
- VEON $34.87
- Resistance Level
- NEO $18.20
- VEON $36.86
- Average True Range (ATR)
- NEO 0.70
- VEON 1.49
- MACD
- NEO -0.28
- VEON 0.23
- Stochastic Oscillator
- NEO 6.41
- VEON 86.28
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
About VEON VEON Ltd. ADS
VEON Ltd is a global provider of connectivity and internet services. The company provides its customers with voice, fixed broadband, data, and digital services. Currently, the company offers services to customers in the following countries: Pakistan, Ukraine, Kazakhstan, Bangladesh, Uzbekistan, and Kyrgyzstan. The reportable segments currently consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. The company provides services under the Beeline, Kyivstar, banglalink and Jazz brands.